Hoover R G, Hickman S, Gebel H M, Rebbe N, Lynch R G
J Clin Invest. 1981 Jan;67(1):308-11. doi: 10.1172/JCI110028.
Lymphocytes obtained from the blood of normal individuals and six patients with newly diagnosed multiple myeloma were separated into T and non-T cell populations by rosette-formation with sheep erythrocytes, and were then assayed for the presence of surface membrane Fc receptors. When compared with normal individuals, four patients with IgG myeloma had a three- to fourfold increase in T cells with IgG receptors (T gamma cells) and two patients with IgA myeloma had a two- to threefold increase in T cells with IgA receptors (T alpha cells). Patients with IgG or IgA myeloma had normal numbers of non-T lymphocytes with surface receptors for IgG and IgA, respectively. The finding that human myeloma is accompanied by elevated numbers of T cells with Fc receptors for the heavy chain class of the myeloma protein: (1) may account for the apparent "monoclonal" lymphocyte population in patients with myeloma; (b) extends to humans similar observations made in mice with secretory plasmacytomas; and (c) is of interest because T cells with Fc receptors are immunoregulatory lymphocytes.
从正常个体及六名新诊断的多发性骨髓瘤患者血液中获取的淋巴细胞,通过与绵羊红细胞形成玫瑰花结,分离为T细胞群和非T细胞群,然后检测其表面膜Fc受体的存在情况。与正常个体相比,四名IgG型骨髓瘤患者中带有IgG受体的T细胞(Tγ细胞)增加了三到四倍,两名IgA型骨髓瘤患者中带有IgA受体的T细胞(Tα细胞)增加了两到三倍。IgG或IgA型骨髓瘤患者中,分别带有针对IgG和IgA表面受体的非T淋巴细胞数量正常。人类骨髓瘤伴有骨髓瘤蛋白重链类别的Fc受体的T细胞数量增加这一发现:(1)可能解释了骨髓瘤患者中明显的“单克隆”淋巴细胞群;(b)扩展到了人类,类似于在分泌性浆细胞瘤小鼠中所做的观察;(c)很有意思,因为带有Fc受体的T细胞是免疫调节淋巴细胞。